285 related articles for article (PubMed ID: 26037953)
41. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
Trivedi P; Hematti P
Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856
[TBL] [Abstract][Full Text] [Related]
42. Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism.
Yan Z; Zhuansun Y; Chen R; Li J; Ran P
Exp Cell Res; 2014 May; 324(1):65-74. PubMed ID: 24681107
[TBL] [Abstract][Full Text] [Related]
43. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
44. Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts-a paired sample study.
Talwadekar MD; Kale VP; Limaye LS
Sci Rep; 2015 Oct; 5():15784. PubMed ID: 26507009
[TBL] [Abstract][Full Text] [Related]
45. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.
Lin W; Oh SK; Choo AB; George AJ
Cytotherapy; 2012 Mar; 14(3):274-84. PubMed ID: 22136295
[TBL] [Abstract][Full Text] [Related]
46. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.
Hemeda H; Jakob M; Ludwig AK; Giebel B; Lang S; Brandau S
Stem Cells Dev; 2010 May; 19(5):693-706. PubMed ID: 20067407
[TBL] [Abstract][Full Text] [Related]
47. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
[TBL] [Abstract][Full Text] [Related]
48. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
[TBL] [Abstract][Full Text] [Related]
49. Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.
Yang H; Sun J; Wang F; Li Y; Bi J; Qu T
Oncotarget; 2016 Nov; 7(45):72537-72545. PubMed ID: 27705922
[TBL] [Abstract][Full Text] [Related]
50. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
51. [Immunoregulatory effect of bone marrow mesenchymal stem cells on regulatory T cells in patients with systemic lupus erythematosis].
Sun Y; Zhang FS; Zhang ZY
Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):1018-21. PubMed ID: 18478921
[TBL] [Abstract][Full Text] [Related]
52. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.
Ryan JM; Barry F; Murphy JM; Mahon BP
Clin Exp Immunol; 2007 Aug; 149(2):353-63. PubMed ID: 17521318
[TBL] [Abstract][Full Text] [Related]
53. Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes.
Del Fattore A; Luciano R; Pascucci L; Goffredo BM; Giorda E; Scapaticci M; Fierabracci A; Muraca M
Cell Transplant; 2015; 24(12):2615-27. PubMed ID: 25695896
[TBL] [Abstract][Full Text] [Related]
54. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
55. The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia.
Zhao ZG; Xu W; Sun L; Li WM; Li QB; Zou P
Eur J Cancer; 2012 Aug; 48(12):1884-95. PubMed ID: 22129888
[TBL] [Abstract][Full Text] [Related]
56. Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.
Guo H; Zhao N; Gao H; He X
Scand J Immunol; 2017 Nov; 86(5):389-395. PubMed ID: 28888053
[TBL] [Abstract][Full Text] [Related]
57. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
[TBL] [Abstract][Full Text] [Related]
58. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model.
Jia Z; Jiao C; Zhao S; Li X; Ren X; Zhang L; Han ZC; Zhang X
Exp Eye Res; 2012 Sep; 102():44-9. PubMed ID: 22800963
[TBL] [Abstract][Full Text] [Related]
59. Immunomodulatory effect of bone marrow mesenchymal stem cells on T lymphocytes in patients with decompensated liver cirrhosis.
Guo CH; Han LX; Wan MR; Deng GJ; Gan JH
Genet Mol Res; 2015 Jun; 14(2):7039-46. PubMed ID: 26125913
[TBL] [Abstract][Full Text] [Related]
60. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses.
de Mare-Bredemeijer EL; Mancham S; Verstegen MM; de Ruiter PE; van Gent R; O'Neill D; Tilanus HW; Metselaar HJ; de Jonge J; Kwekkeboom J; Hall SR; van der Laan LJ
Stem Cells Dev; 2015 Jun; 24(12):1436-47. PubMed ID: 25744002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]